Navigation Links
Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
Date:10/6/2008

Vice President and Chief Medical Officer at Ironwood.

"These novel findings provide valuable insight into the possible role of cGMP in alleviating intestinal pain and may explain the reduction in intestinal pain observed in patients with IBS-C treated with linaclotide in our Phase 2b studies," said Mark Currie, Ph.D., Senior Vice President, R&D and Chief Scientific Officer at Ironwood.

About Linaclotide

Linaclotide is a first-in-class compound currently being evaluated for the treatment of IBS-C, chronic constipation (CC), and other gastrointestinal disorders. Linaclotide was designed to exert its effect on the intestine with minimal systemic exposure. Linaclotide is an agonist of guanylate cyclase type-C, a receptor found on the lining of the intestine. Linaclotide demonstrated proof of concept in a comprehensive Phase 2b program, comprised of two clinical studies in over 700 patients with either IBS-C or CC. In patients with IBS-C, linaclotide reduced abdominal pain and relieved constipation-the hallmarks of the condition-throughout the 12-week treatment period. In patients with CC, linaclotide reduced constipation throughout the 4-week study period. Linaclotide was well tolerated at all doses in both Phase 2b studies, with the most common adverse event being diarrhea. A United States patent covering linaclotide composition of matter expires in 2025. In September 2007, Ironwood and Forest Laboratories entered into a 50/50 collaboration to co-develop and co-promote linaclotide in the United States. Ironwood retains exclusive rights to linaclotide outside of North America.

About Irritable Bowel Syndrome (IBS)

One out of six adults in developed countries suffers from IBS, a chronic condition marked by abdominal pain and disturbed bowel function. IBS accounts for 12% of adult visits to primary care physicians and is the most common disorder diagnosed by gastroenterologists. Healthcare costs associated with IBS exceed $25 billion ann
'/>"/>

SOURCE Ironwood Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
3. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
4. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
5. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Sept. 18, 2014  ePharmaSolutions, the leading ... as the Disruptive Innovator of the Year ... eClinical platform. This solution includes an integrated ... file (eTMF), a remote monitoring application, eSource ... patient screening and matching technology. ...
(Date:9/18/2014)... ARBOR, Mich. , Sept. 18, 2014  A ... Research will allow the University of Michigan to establish ... The Glenn Center for Aging Research at ... evidence that drugs can slow the effects of aging ... unlock mechanisms of aging that can help develop medications ...
(Date:9/18/2014)... , Sept. 18, 2014   3D Systems   (NYSE: ... Simbionix RobotiX Mentor™ , a new robotic surgery skills ... first time at the ERUS exhibition in Amsterdam, ... #7). Robotic-assisted minimally invasive surgery represents a growing ... the needs for training for robotic surgery has increased, and ...
Breaking Medicine Technology:ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 2ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 33D Systems Introduces New Simbionix Robotics Training Platform 23D Systems Introduces New Simbionix Robotics Training Platform 3
... Genetic Risk Based on Clinical Data, ... WALTHAM, Mass., July 22 Interleukin Genetics,Inc. ... of an enhanced test report,format and information package ... is currently marketed under the brand name Gensona(R) ...
... YORK, July 21 Ari Kiev, M.D., president of ... upcoming conference Wall,Street Unplugged: The Trout Group Investor Seminar ... held on Wednesday, July 30, at Midtown,Loft & Terrace, ... targeted to CEOs,and CFOs at private and small and ...
Cached Medicine Technology:Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3
(Date:9/18/2014)... TayganPoint Consulting Group, a leading ... and co-founder John Cassimatis was named as one ... 2014, recognizing the region’s top healthcare and life ... of the year. , The Innovation Awards celebrate ... continue to shape the medical industry in Greater ...
(Date:9/18/2014)... Ben Quirk, CEO of Quirk Healthcare Solutions, was ... the Savannah Science Seminar in recognition for the firm’s ... and especially in Savannah. , “I am humbled and ... Science Seminar is an amazing program that has been ... through the program,” he added. Eleventh graders from private ...
(Date:9/18/2014)... of international scientists have developed a new method to ... . , The Wildlife Conservation Society (WCS)-led research, published ... , describes the use of fecal samples from wild ... exposed to the virus. This represents a new tool ... change the way Ebola virus is studied and improve ...
(Date:9/18/2014)... The National Institutes of Health (NIH) recently awarded the ... grant to the Los Angeles Biomedical Research Institute (LA ... a vaccine to protect patients from the healthcare-related infections, ... (MRSA). , The National Institute of Allergy and ... to LA BioMed infectious disease specialists John E. Edwards, ...
(Date:9/18/2014)... been trying to develop tools that would allow them ... first moment a neuron fires to the resulting behavior ... neuroscientists are working to develop a range of new ... developed one such tool that provides a new way ... The worka collaboration between Viviana Gradinaru (BS ,05), assistant ...
Breaking Medicine News(10 mins):Health News:TayganPoint Executive Receives Prestigious Award from Philadelphia Business Journal 2Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 3Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2Health News:Sensing neuronal activity with light 2Health News:Sensing neuronal activity with light 3Health News:Sensing neuronal activity with light 4Health News:Sensing neuronal activity with light 5
... SHENZHEN, CHINA , March 15 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/ ) is pleased to announce that the Chilean government approved two of the company,s ... ... ... ...
... by dying cancer patients to the emergency department can be ... Canadian Medical Association Journal ( CMAJ ) (pre-embargo ... patients visit the emergency department in the last 2 weeks ... often and why people dying of cancer visit the emergency ...
... locating and avoiding nerves during spinal procedures, suggests a ... issue becomes important for patients as the demand for ... the need for effective methods for monitoring the location ... Mechanomyography (MMG) systems function by measuring the mechanical ...
... boost outcomes after 12 months, new study finds , MONDAY, ... alone to patients who have had stents implanted seems just ... Plavix, a new study finds. , Researchers discovered that, after ... went off Plavix and just took aspirin had the same ...
... Each year, nearly three million youths run away from home, ... mental illness.  In honor of National Safe Place Week, National Safe Place ... to raise awareness of the risks associated with teen homelessness and the ... youth in crisis.   , ...
... Open defecation – the riskiest sanitation practice – is on the decline worldwide , ... , , ... ... GENEVA and NEW YORK , March ...
Cached Medicine News:Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 2Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 3Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 4Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 5Health News:Dying cancer patient visits to emergency departments can be avoided 2Health News:Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery 2Health News:Aspirin Alone Works Best to Prevent Clots a Year After Stenting 2Health News:Aspirin Alone Works Best to Prevent Clots a Year After Stenting 3Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 2Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 3Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 4Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 5Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 6Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 7Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 8Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 2Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 3Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 4Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 5Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 6Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 7
2 mm wide tip with 1 mm by 4 mm eye. Curved shaft and ring handle with polished finish....
Coaptation forceps. Insulated....
Titanium bayonet forceps. Insulated....
Gerald bayonet forceps. Insulated....
Medicine Products: